Drug name - Vivitrol
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7919499 | ALKERMES | Naltrexone long acting formulations and methods of use |
Oct, 2029
(7 years from now) | |
Drugs and Companies using NALTREXONE ingredient
Treatment: Prevention of relapse to opioid dependence, following opioid detoxification; treatment of alcohol dependence
Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 380MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.